Shinya Goto Selected Research

Cerebral Hemorrhage

1/2021	Reexamination of the Embolic Stroke of Undetermined Source Concept.
12/2014	New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinya Goto Research Topics

Disease

67	Stroke (Strokes) 12/2023 - 12/2005
57	Atrial Fibrillation 12/2023 - 11/2008
51	Hemorrhage 01/2023 - 12/2005
36	Myocardial Infarction 04/2024 - 03/2002
36	Thrombosis (Thrombus) 01/2023 - 07/2002
21	Acute Coronary Syndrome 01/2020 - 01/2009
20	Embolism (Embolus) 12/2023 - 09/2011
19	Heart Failure 04/2024 - 01/2003
14	Ischemic Stroke 11/2019 - 12/2006
11	Venous Thromboembolism 01/2023 - 09/2016
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 09/2008
9	Diabetes Mellitus 10/2023 - 09/2008
9	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 12/2005
9	Hypertension (High Blood Pressure) 05/2021 - 04/2005
8	Vascular Diseases (Vascular Disease) 05/2021 - 10/2009
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 01/2012
7	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2010
7	Hemorrhagic Stroke 08/2017 - 09/2011
6	Disease Progression 12/2023 - 01/2017
6	Unstable Angina 10/2021 - 03/2002
5	Chronic Renal Insufficiency 04/2024 - 01/2019
5	Neoplasms (Cancer) 01/2023 - 01/2013
5	Transient Ischemic Attack 11/2019 - 12/2006
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2016 - 01/2006
5	Peripheral Arterial Disease 04/2016 - 03/2013
4	Thromboembolism 05/2021 - 09/2014
4	Infections 01/2020 - 01/2017
3	Ischemia 10/2023 - 05/2011
3	Persistent Infection 09/2023 - 01/2017
3	Deltaretrovirus Infections (BLV Infection) 01/2022 - 01/2018
3	Paratuberculosis (Johne's Disease) 01/2020 - 01/2018
3	Thrombocytopenia (Thrombopenia) 01/2015 - 01/2003
3	Atherosclerosis 12/2014 - 08/2013
3	Ulcer 07/2014 - 06/2009
2	Kidney Diseases (Kidney Disease) 04/2024 - 12/2023
2	Inflammation (Inflammations) 12/2023 - 07/2012
2	Infarction (Infarctions) 10/2023 - 01/2009
2	COVID-19 08/2023 - 02/2023
2	Pathologic Constriction (Stenosis) 01/2023 - 09/2019
2	Overweight 12/2021 - 11/2010
2	Obesity 06/2021 - 07/2007
2	Anemia 01/2021 - 12/2016
2	Cerebral Hemorrhage 01/2021 - 12/2014
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2019
2	ST Elevation Myocardial Infarction 01/2019 - 05/2017
2	Dyslipidemias (Dyslipidemia) 01/2018 - 01/2014

Drug/Important Bio-Agent (IBA)

52	AnticoagulantsIBA 12/2023 - 01/2008
27	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 01/2009
24	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 04/2010
23	Vitamin K FDA Link 10/2022 - 09/2011
15	apixabanIBA 01/2021 - 09/2011
14	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 08/2002
13	RivaroxabanIBA 05/2017 - 05/2011
12	Clopidogrel (Plavix)FDA Link 02/2019 - 01/2009
10	TicagrelorIBA 01/2023 - 07/2014
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2006
7	von Willebrand FactorIBA 10/2022 - 07/2002
6	Factor Xa InhibitorsIBA 05/2021 - 05/2011
6	Thrombin FDA Link 07/2019 - 01/2010
6	vorapaxarIBA 04/2016 - 02/2010
6	Thrombin Receptors (Thrombin Receptor)IBA 04/2016 - 01/2010
6	Adenosine Diphosphate (ADP)IBA 07/2014 - 01/2010
5	empagliflozinIBA 04/2024 - 12/2023
5	CreatinineIBA 12/2023 - 11/2010
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021 - 01/2004
5	Glycoproteins (Glycoprotein)IBA 01/2015 - 07/2002
4	LipidsIBA 10/2023 - 04/2017
4	FibrinIBA 10/2023 - 01/2006
4	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2018
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2017 - 07/2013
4	Factor Xa (Coagulation Factor Xa)IBA 12/2016 - 01/2012
4	E 5555IBA 07/2012 - 11/2010
3	CholesterolIBA 10/2022 - 12/2006
3	AntithrombinsIBA 05/2021 - 03/2015
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020 - 01/2018
3	LigandsIBA 01/2018 - 01/2017
3	omega-Chloroacetophenone (Mace)IBA 10/2017 - 02/2010
3	Peptide Hydrolases (Proteases)FDA Link 04/2016 - 01/2010
3	Prasugrel Hydrochloride FDA Link 01/2015 - 01/2013
3	Cilostazol (Pletal)FDA LinkGeneric 11/2009 - 12/2005
3	Platelet Membrane Glycoprotein IIbIBA 01/2006 - 03/2002
2	CytokinesIBA 12/2023 - 01/2020
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2023 - 08/2013
2	Insulin (Novolin)FDA Link 10/2023 - 08/2013
2	Messenger RNA (mRNA)IBA 08/2023 - 02/2023
2	CollagenIBA 10/2022 - 07/2002
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2022 - 01/2018
2	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 01/2006
2	Caffeine (No Doz)FDA LinkGeneric 01/2020 - 12/2010
2	B7-H1 AntigenIBA 01/2019 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 05/2017 - 07/2012

Therapy/Procedure

60	Therapeutics 12/2023 - 01/2006
11	Secondary Prevention 01/2020 - 12/2005
8	Percutaneous Coronary Intervention 01/2023 - 12/2010
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 05/2011
3	Carotid Endarterectomy 04/2017 - 12/2006
3	Stents 01/2017 - 08/2002
2	Lasers (Laser) 10/2022 - 01/2010
2	Blood Transfusion (Blood Transfusions) 02/2020 - 05/2015
2	Endarterectomy (Thromboendarterectomy) 04/2017 - 12/2006